chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lymphoma /Diffuse large B cell lymphoma (DLBCL); This is a spontaneous report from a contactable consumer (the patient).     A 71-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 19Mar2021 (Batch/Lot Number: EN6208) as as single dose  for covid-19 immunisation  .  The patient medical history and concomitant medications were not reported.  The patient experienced lymphoma /diffuse large b cell lymphoma (DLBCL)  (medically significant) in 2021 with outcome of unknown.   Unknown therapeutic measures were taken as a result of lymphoma /diffuse large b cell lymphoma. The patient stated the lymphoma first appeared between the first and second dose. Caller stated that he is under the care of a doctor and is being treated for the lymphoma. He also added that received the second dose on 09APR2021, lot number ER8729. Also he is an "exceptionally healthy, senior athlete" and he is scared to death.  Follow-up attempts are completed. No further information is expected.
Patient reported facial flushing, intermittent SOB and chest discomfort/tightness 15min after 1st dose of COVID-19 Pfizer vaccine. Patient was given 10mg PO Zertec. Vitals stable. Lung sounds clear. Symptoms slowly resolving. Patient monitored for 1 hour by triage RN and PA . Patient discharged home with Husband. Educated to report to ED for eval if hypersensitivity reaction worsens or she has any type of rebound allergic reaction while at home.
Redness, hard, painful, cellulitis on left deltoid. Fever 103 within 24 hrs.
One week after receiving vaccine, 1st dose, severe left shoulder, neck, ear, and left temple pain.  Throbbing and what feels like joint pain.  Severe headaches. Left side of face experiencing partial paralysis. Lips cannot pucker, left eyelid will not blink unless forced, slight drooping of jowl. Drooling at night from left side. Tongue has areas of numbness.
Alopecia areata 2cm in one spot of head found out on 28 July 2021  Alopecia areata worsen to 4cm on the same spot after second dose in August 2021  New Alopecia areata 1cm spotted in another spot after Moderna booster shot in End January 2022
Second dose of vaccine given one day early (day 16). No acute changes to patient health status.
Pt reports "shingles" outbreak. MD saw pt on 4/10, no evidence of shingles. Pt reports pain on neck, and scalp. MD reports that this is described similar to PHN pain. This is a different dermatome then pt's history of PHN. Pt treated with Lidocaine 5% oint., LYRICA 75 mg BID and Tramadol 50 mg PRN.
Fever 101.7 degrees F on 4/22/2021. Severe headache a whole day. Muscle pains. Taking vitamin C and orange juice.  On 4/23/2021: super sore throat, jaw: super sore, chest: pain near the top of the sternum bone, between clavicle bones, head feels like burning. currently taking two pills of acetaminophen 325mg and phenylephrine HCl 5mg.
SHORT OF BREATH, CHEST TIGHTNESS, NAUSEA/VOMITING, THEN SLOW TO RESPOND. 911 CALLED, BENADRYL & EPINEPHRINE ADMINISTERED. PATIENT TAKEN TO HOSPITAL BY AMBULANCE BUT RELEASED SAME DAY
Approximately 2 months after my 4th dose vaccination I contracted COVID-19 and experienced the following symptoms: Congestion and Fatigue. I did not take any treatment instead I called my Doctor and he advised me to go to the Emergency Room to have a antiviral treatment of Monoclonal Antibody.  After 36 hours I felt so much better just a little fatigue but not as worse as before. As of today 07/08/2022 i re-tested myself and finally tested negative for COVID-19 but still experiencing some fatigue and congestion.
face numb and tingly 45 minutes post vaccination. headache immediately and still continues today (9-7-2021)
Patient complained of numbness in both arms and then chest pain following injection.  Ambulance was called and treated patient .
Patient accidentally received a fifth injection of Ipol after already completing the four dose series before/No AE; Initial information received on 04-Sep-2020 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 12 years old male patient who on 03-Sep-2020 accidentally received a fifth injection of IPV (VERO) [IPOL] after already completing the four dose series before (extra dose administered).  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HPV VACCINE VLP RL1 4V (YEAST) (GARDASIL HP) and MENINGOCOCCAL VACCINE B (MENINGOCOCCAL VACCINE B) for Immunisation.  On an unknown date the patient received first, second, third and fourth dose of suspect IPV (VERO) (lot number and expiry date not reported) via unknown route at an unknown administration site and on 03-Sep-2020, the patient received a 0.5 mL fifth  dose of same vaccine (injection, lot R1B251M and expiry date 13-Mar-2021) via subcutaneous route in the right arm for prophylactic vaccination.  It was an actual medication error case due to extra dose administered.  Case details: It was reported by the nurse that a fill in data entry clerk accidentally pulled up the wrong brother's name (they had very similar names) and the vaccines that were scheduled were given to the wrong brother. Because of this, Ipol was inadvertently given to a 12 year old patient who already had completed the four Ipol injection series and this was an unnecessary dose. The patient did not experience any adverse events due to this.  At the time of reporting, patient did not experience any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There will be no information available on the batch number (first, second, third and fourth doses) for this case.
Once when he got Covid one time, she tested positive and he was negative/had chest x-ray and was told he had viral pneumonia caused by Covid; Once when he got Covid one time, she tested positive and he was negative/had chest x-ray and was told he had viral pneumonia caused by Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID.  A 70-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "kidney stones" (unspecified if ongoing), notes: few years back he had kidney stones; "Diabetec" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "not recovered", described as "Once when he got Covid one time, she tested positive and he was negative/had chest x-ray and was told he had viral pneumonia caused by Covid"; COVID-19 PNEUMONIA (medically significant), outcome "not recovered", described as "Once when he got Covid one time, she tested positive and he was negative/had chest x-ray and was told he had viral pneumonia caused by Covid ". The patient underwent the following laboratory tests and procedures: Body height: (unspecified date) 5 foot 8 or 5 foot 9; Body temperature: (unspecified date) around 99-101, notes: fever around 99-101; Chest X-ray: (unspecified date) viral pneumonia; SARS-CoV-2 test: (02Aug2023) Positive; (unspecified date) Positive, notes: He tested positive; (unspecified date) Negative, notes: he was negative. Clinical course: Once when he got Covid one time, she tested positive and he was negative, she got x-ray and told no pneumonia and the following week he was coughing, coughing, coughing, and went back a week later positive for Covid. Didn't have any medicines and they were ok. He had chest x-ray and was told he had viral pneumonia caused by Covid and nothing to give him. Was a good over a year ago when this happened. She found interesting when they said viral pneumonia and couldn't give anything. Weren't put on any medication that was before this Paxlovid that came out later. It was all before they had the booster. They had a couple of shots, 1 or 2 before this.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
getting moderna booster dose (0.25) but recieved full dose of 0.5 moderna dose by mistake
Felt like I was floating at first, then turned into sweating, massive fatigue and chills very quickly. Fever, chills, body aches (every single muscle in my body was in pain). Sore arm, enlarged arm and rash at site of injection that was the size of two hockey pucks. Nausea and headache. Enlarged glands under arm, neck and groin. Largest one in neck.
Patient came in for first dose of COVID vaccine and received the Bivalent booster instead of the original COVID vaccination that should be given for the first dose. Contributing factors where busy clinic afternoon, not knowing that Bivalent was only to be given as a third dose for 12 years and older only and not as a first dose, also not having a double check. It was discovered when I was going to chart it in the system and lot number was not matching.  Vaccine administered was Bivalent, 0.3ml, IM in left arm.  My recommendation is to check lot number before drawing up, insuring new staff is properly educated before administrating vaccines, having someone else double check vaccine and taking that extra step when busy to verify.
Initially had injection site  w/ pain then following day developed nausea and dizziness.  Since vaccine has had multiple symptoms:  severe hair loss,  trouble thinking (foggy thinking w/ memory loss), severe fatigue, paresthesia's, joint pain in lower extremities and intermittent swelling at ankles.
Immunizations were given at doctors office on 7/7/08.  Patient woke up on 7/8/08 with fever running between 101-103. No vomiting, diarrhea, or other symptoms.
The patient complained of rash on bilateral arms, chest, neck. Denies shortness of breath. The patient took over the counter Benadryl at home. Patient received 0.3mg Epinephrine IM and Benadryl 50mg IM in urgent care
Fatigue (about one week from injection); red ring almost around the entire circumference of arm approx 2 inches below the injection site
developed runny nose 24 hrs after receiving first dose of vaccine. Runny nose improved in 3 days.  Also had intermittent mild headache  for 2 days after first dose of vaccine. Still had nasal congestion 7 days later. Reported adverse side effects to my hospital's employee health on Saturday Jan 2,2021. Employee health had me leave work at noon time on Saturday Jan 2, 2021 to be swabbed for covid.
Pt. developed erythematous, pruritic rash that started at elbow and continued to site of injection. Pt. contacted pharmacy and then went to primary care physician for treatment.
The patient stated that he has had a sore left arm since he got the vaccine over 2 weeks ago. He demonstrated that it was hard to lift his left arm above shoulder height.
This spontaneous report as received from a nurse practitioner refers to a female patient of unknown age. The patient administered her first dose of GARDASIL in January 2010 and her second dose in January 2012 intramuscularly (dose and lot # not reported). No adverse effect reported. It was unspecified if the patient sought medical attention. Additional information has been requested.
at 10:25  Pt stated heart rate elevated- 130, feeling like throat tightening. Pt took own albuterol inhaler. At 10:28 still progressing and she administered her own epipen.. , Hr at 107.Throat felt better.  EMS called  Transferred to EMS at 10:37. At that time her throat was starting to tighten again.
This spontaneous report was received from a pharmacist and refers to a patient of unknown demographics. The patient's pertinent medical history, concurrent conditions, concomitant medications, past drugs and drug allergies were not reported. On an unknown date, the patient was vaccinated with improperly stored ZOSTAVAX (lot # M042851, expiry date: 18-JAN-2018) for prophylaxis. No information was available for sterile diluent used to re-constitute the improperly stored ZOSTAVAX. No adverse effects were reported. The ZOSTAVAX was stored at a temperature of 70 Fahrenheit (F) for 18 hours (dates were not reported). There were no previous temperature excursions. The digital data logger was not involved. No Product Quality Complaint (PQC) was involved. Additional information is not expected, no contact details were provided.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 64-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Dec2022 as dose number unknown (booster), single (Lot number: GL0446) at the age of 63 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Zofran, reaction(s): "Known allergies: Zofran"; Sulpha drugs, reaction(s): "Known allergies: Sulpha drugs". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "recovered" (2023) and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2023) Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid from 08Aug2023 to 13Aug2023.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300278886 Same patient, different drug/ AE;
9/20 at around 11.45 am while driving home from vet, felt weak, my heart was pounding went home straight to bed, for around 20 minutes, my heart was beating at around 200, eventually it went back to normal. On 9/21 went to see my primary care physician to get checked out, doctor prescribed beta blocker, on my way to the pharmacy my heart started pounding again, went to the pharmacy and ask that my prescription be filled immediately, my heart was racing for 20 minutes, but I took a beta blocker and then anyone and called paramedic, my pulse went down to about 130 and I left to go home shortly afterwards. Went to a cardiologist on 9/25, Dr ordered a heart monitor and an echo 3 weeks later, nothing significant was found to account for the two episodes.
Patient started having extreme joint aching.  Took Tylenol and thought would go away.  Did not go away and after 3 days she went to see her physician.  He said to continue to take Tylenol and it should go away.  It has been 12 days and pain has not let up.  Pain is unrelenting and particularly bad in right arm and wrist.
First symptom at about 9:15 PM was itching in chest. Started coughing, and chest began to tighten.  During the next 30 minutes, chest kept getting tighter and breathing became difficult. Started wheezing, and it felt like I was breathing through a straw.  Coughing continued w/ diaphoresis and rapid heartbeat. Went to the ER around 10:15 PM. Blood tests were normal; chest x-ray was normal; EKG was abnormal, but was later dismissed. Nebulizer treatment was administered (Duo-Neb). Returned home at 2:00 AM and was able to breathe much better.  Lips and mouth were swollen the following day, chest was sore.
Bottom of spine feels like someone is squeezing it and has a burning sensation; Bottom of spine feels like someone is squeezing it and has a burning sensation; Experiencing the same thing in testicles; Legs numb for 5 minutes/could move his legs but not toes.; Tired, had body fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Legs numb for 5 minutes/could move his legs but not toes.), BACK PAIN (Bottom of spine feels like someone is squeezing it and has a burning sensation), BURNING SENSATION (Bottom of spine feels like someone is squeezing it and has a burning sensation), TESTICULAR PAIN (Experiencing the same thing in testicles) and FATIGUE (Tired, had body fatigue) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, the patient experienced FATIGUE (Tired, had body fatigue). On 19-May-2021, the patient experienced HYPOAESTHESIA (Legs numb for 5 minutes/could move his legs but not toes.). On 20-May-2021, the patient experienced BACK PAIN (Bottom of spine feels like someone is squeezing it and has a burning sensation), BURNING SENSATION (Bottom of spine feels like someone is squeezing it and has a burning sensation) and TESTICULAR PAIN (Experiencing the same thing in testicles). At the time of the report, HYPOAESTHESIA (Legs numb for 5 minutes/could move his legs but not toes.), BACK PAIN (Bottom of spine feels like someone is squeezing it and has a burning sensation), BURNING SENSATION (Bottom of spine feels like someone is squeezing it and has a burning sensation), TESTICULAR PAIN (Experiencing the same thing in testicles) and FATIGUE (Tired, had body fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Follow up was received on 20 May 2021 included additional events. Updated events are bottom of spine feels like someone is squeezing it and has a burning sensation, experiencing the same thing in testicles.
experienced fatigue 3 days after the shot; warm sensation creeping from myshot location down my left arm into myhands; hand became harder tosqueeze, almost weak and left hand was still weak; the worst part is my right hip, (all on right side) in pain.; the worst part is my low back (all on right side) in pain.; the worst part is my groin (all on right side) in pain.; couldn't move without being in pain; Then warm sensation then went down my spineand my low back and neck started getting extremely warm; as well as a couple days of hot/cold feelings,; lymph nodes in my groin right side are inflamed, still; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) in the left arm on 05Apr2021 at 11:00 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included right mastoid bone removed due to swelling/drainage issues when the patient was 5-year-old. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN, not the day of) on unknown date and unknown if its ongoing for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 11:45, probably 30 minutes after the shot, the patient experienced a warm sensation creeping from shot location down to left arm into hands. On 05Apr2021, The patient experienced hand became harder to squeeze, almost weak. The warm sensation then went down to spine and low back and neck started getting extremely warm. By the evening, arm was killing, left hand was still weak. On 05Apr2021, the patient experienced the worst part of pain in her right hip, low back, groin (all on right side) and by the end of the night, the patient couldn't move without being in pain. The hip pain lasted for 4 days, and the patient now almost two weeks out and still had pain in groin/right hip area. The patient was pretty certain that lymph nodes in groin right side were inflamed, still. On 08Apr2021, 3 days after the shot, the patient experienced fatigue. On an unknown date in Apr2021, the patient experienced hot/cold feelings for a couple of days. It was reported that the patient was constantly taking and putting her sweater on to warm up or cool off. No therapeutic measures were taken as a result of the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events warm sensation creeping from shot location down to the left arm into the hands, hand became harder to squeeze, almost weak, pain in right hip, low back, and groin (all on right side), couldn't move without being in pain, lymph nodes in groin right side were inflamed, fatigue, hot/cold feelings were resolving at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Severe back, neck, chest, muscle and joint pain. Headache, chills/ sweats, fatigue, dizziness, and nausea.
Red skin scarring; Tenderness - Near Vaccination  Site; Redness - NearVccination Site; Swelling - Near Vaccination Site; Hot to Touch Sensation - Near vaccination Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to Touch Sensation - Near vaccination Site), ERYTHEMA (Red skin scarring), TENDERNESS (Tenderness - Near Vaccination  Site), VACCINATION SITE ERYTHEMA (Redness - NearVccination Site) and VACCINATION SITE SWELLING (Swelling - Near Vaccination Site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Bigeminy, Hypertension, Type II diabetes mellitus, Shellfish allergy and Drug allergy. Concomitant products included HCTZ, METFORMIN, ATORVASTATIN CALCIUM (LIPITOR) and ATENOLOL for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot to Touch Sensation - Near vaccination Site), TENDERNESS (Tenderness - Near Vaccination  Site), VACCINATION SITE ERYTHEMA (Redness - NearVccination Site) and VACCINATION SITE SWELLING (Swelling - Near Vaccination Site). On 09-Feb-2021, the patient experienced ERYTHEMA (Red skin scarring). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) (oral) for Adverse event, at a dose of 1-2, prn and CEFALEXIN for Adverse event, at an unspecified dose and frequency. On 06-Mar-2021, VACCINATION SITE WARMTH (Hot to Touch Sensation - Near vaccination Site), ERYTHEMA (Red skin scarring), TENDERNESS (Tenderness - Near Vaccination  Site), VACCINATION SITE ERYTHEMA (Redness - NearVccination Site) and VACCINATION SITE SWELLING (Swelling - Near Vaccination Site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-259356 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up received on 14-JUL-2021 contains patient demographic information, race information, medical history, concomitant drugs information.